2007 Disease Immune Response Molecular Biology 
Dark Matter Blog
JULY 16, 2021
The only subject in school that held my interest was biology. As soon as I learned about DNA and RNA, I wanted to be a molecular biologist. I wanted to use molecular biology to create drugs. Synta was focused on small molecule drug discovery and development in oncology and inflammatory diseases.
Drug Discovery World
MAY 12, 2023
José Mejía Oneto , PhD, Founder and CEO at Shasqi, discusses the potential of chemistry to engineer biology to improve the effectiveness of human therapeutics and revolutionise the treatment of disease. This simple and elegant chemistry concept has the potential to revolutionise how we treat disease. The possibilities are vast.
Expert insights. Personalized for you.
52 
Let's personalize your content